1 Study Coverage 1.1 Direct-to-consumer Disease Risk and Health Genetic Test Product Introduction 1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Outlook 2017 VS 2022 VS 2028 1.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in US$ Million for the Year 2017-2028 1.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume for the Year 2017-2028 1.3 United States Direct-to-consumer Disease Risk and Health Genetic Test Outlook 2017 VS 2022 VS 2028 1.3.1 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in US$ Million for the Year 2017-2028 1.3.2 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume for the Year 2017-2028 1.4 Direct-to-consumer Disease Risk and Health Genetic Test Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Direct-to-consumer Disease Risk and Health Genetic Test in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Direct-to-consumer Disease Risk and Health Genetic Test Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Direct-to-consumer Disease Risk and Health Genetic Test Market Dynamics 1.5.1 Direct-to-consumer Disease Risk and Health Genetic Test Industry Trends 1.5.2 Direct-to-consumer Disease Risk and Health Genetic Test Market Drivers 1.5.3 Direct-to-consumer Disease Risk and Health Genetic Test Market Challenges 1.5.4 Direct-to-consumer Disease Risk and Health Genetic Test Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Direct-to-consumer Disease Risk and Health Genetic Test Market Segment by Type 2.1.1 Celiac Disease 2.1.2 Parkinson Disease 2.1.3 Alzheimer Disease 2.1.4 Other 2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type 2.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Type 2.3.1 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Direct-to-consumer Disease Risk and Health Genetic Test Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Direct-to-consumer Disease Risk and Health Genetic Test Market Segment by Application 3.1.1 Online 3.1.2 Offline 3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application 3.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Application 3.3.1 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Direct-to-consumer Disease Risk and Health Genetic Test Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Direct-to-consumer Disease Risk and Health Genetic Test Competitor Landscape by Company 4.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Company 4.1.1 Top Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturers Ranked by Revenue (2021) 4.1.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Manufacturer (2017-2022) 4.1.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Manufacturer (2017-2022) 4.1.4 Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Manufacturer (2017-2022) 4.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Concentration Ratio (CR) 4.2.1 Direct-to-consumer Disease Risk and Health Genetic Test Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Direct-to-consumer Disease Risk and Health Genetic Test in 2021 4.2.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturing Base Distribution, Product Type 4.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Direct-to-consumer Disease Risk and Health Genetic Test Product Type 4.3.3 Date of International Manufacturers Enter into Direct-to-consumer Disease Risk and Health Genetic Test Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Company 4.5.1 Top Direct-to-consumer Disease Risk and Health Genetic Test Players in United States, Ranked by Revenue (2021) 4.5.2 United States Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Direct-to-consumer Disease Risk and Health Genetic Test Sales by Players (2020, 2021 & 2022) 5 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Region 5.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size in Volume by Region (2017-2028) 5.2.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Region: 2017-2022 5.2.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Forecast by Region (2023-2028) 5.3 Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size in Value by Region (2017-2028) 5.3.1 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Region: 2017-2022 5.3.2 Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Direct-to-consumer Disease Risk and Health Genetic Test Market Size YoY Growth 2017-2028 6.1.2 North America Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Genetic Test Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Direct-to-consumer Disease Risk and Health Genetic Test Market Size YoY Growth 2017-2028 6.3.2 Europe Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Market Size YoY Growth 2017-2028 6.4.2 Latin America Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 23andMe 7.1.1 23andMe Corporation Information 7.1.2 23andMe Description and Business Overview 7.1.3 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.1.4 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.1.5 23andMe Recent Development 7.2 MyHeritage 7.2.1 MyHeritage Corporation Information 7.2.2 MyHeritage Description and Business Overview 7.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.2.5 MyHeritage Recent Development 7.3 LabCorp 7.3.1 LabCorp Corporation Information 7.3.2 LabCorp Description and Business Overview 7.3.3 LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.3.4 LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.3.5 LabCorp Recent Development 7.4 Myriad Genetics 7.4.1 Myriad Genetics Corporation Information 7.4.2 Myriad Genetics Description and Business Overview 7.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.4.5 Myriad Genetics Recent Development 7.5 Ancestry.com 7.5.1 Ancestry.com Corporation Information 7.5.2 Ancestry.com Description and Business Overview 7.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.5.5 Ancestry.com Recent Development 7.6 Quest Diagnostics 7.6.1 Quest Diagnostics Corporation Information 7.6.2 Quest Diagnostics Description and Business Overview 7.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.6.5 Quest Diagnostics Recent Development 7.7 Gene By Gene 7.7.1 Gene By Gene Corporation Information 7.7.2 Gene By Gene Description and Business Overview 7.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.7.5 Gene By Gene Recent Development 7.8 DNA Diagnostics Center 7.8.1 DNA Diagnostics Center Corporation Information 7.8.2 DNA Diagnostics Center Description and Business Overview 7.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.8.5 DNA Diagnostics Center Recent Development 7.9 Invitae 7.9.1 Invitae Corporation Information 7.9.2 Invitae Description and Business Overview 7.9.3 Invitae Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Invitae Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.9.5 Invitae Recent Development 7.10 IntelliGenetics 7.10.1 IntelliGenetics Corporation Information 7.10.2 IntelliGenetics Description and Business Overview 7.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.10.5 IntelliGenetics Recent Development 7.11 Ambry Genetics 7.11.1 Ambry Genetics Corporation Information 7.11.2 Ambry Genetics Description and Business Overview 7.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Products Offered 7.11.5 Ambry Genetics Recent Development 7.12 Living DNA 7.12.1 Living DNA Corporation Information 7.12.2 Living DNA Description and Business Overview 7.12.3 Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Living DNA Products Offered 7.12.5 Living DNA Recent Development 7.13 EasyDNA 7.13.1 EasyDNA Corporation Information 7.13.2 EasyDNA Description and Business Overview 7.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.13.4 EasyDNA Products Offered 7.13.5 EasyDNA Recent Development 7.14 Pathway Genomics 7.14.1 Pathway Genomics Corporation Information 7.14.2 Pathway Genomics Description and Business Overview 7.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Pathway Genomics Products Offered 7.14.5 Pathway Genomics Recent Development 7.15 Centrillion Technology 7.15.1 Centrillion Technology Corporation Information 7.15.2 Centrillion Technology Description and Business Overview 7.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Centrillion Technology Products Offered 7.15.5 Centrillion Technology Recent Development 7.16 Xcode 7.16.1 Xcode Corporation Information 7.16.2 Xcode Description and Business Overview 7.16.3 Xcode Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Xcode Products Offered 7.16.5 Xcode Recent Development 7.17 Color Genomics 7.17.1 Color Genomics Corporation Information 7.17.2 Color Genomics Description and Business Overview 7.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Color Genomics Products Offered 7.17.5 Color Genomics Recent Development 7.18 Anglia DNA Services 7.18.1 Anglia DNA Services Corporation Information 7.18.2 Anglia DNA Services Description and Business Overview 7.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.18.4 Anglia DNA Services Products Offered 7.18.5 Anglia DNA Services Recent Development 7.19 African Ancestry 7.19.1 African Ancestry Corporation Information 7.19.2 African Ancestry Description and Business Overview 7.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.19.4 African Ancestry Products Offered 7.19.5 African Ancestry Recent Development 7.20 Canadian DNA Services 7.20.1 Canadian DNA Services Corporation Information 7.20.2 Canadian DNA Services Description and Business Overview 7.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.20.4 Canadian DNA Services Products Offered 7.20.5 Canadian DNA Services Recent Development 7.21 DNA Family Check 7.21.1 DNA Family Check Corporation Information 7.21.2 DNA Family Check Description and Business Overview 7.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.21.4 DNA Family Check Products Offered 7.21.5 DNA Family Check Recent Development 7.22 Alpha Biolaboratories 7.22.1 Alpha Biolaboratories Corporation Information 7.22.2 Alpha Biolaboratories Description and Business Overview 7.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.22.4 Alpha Biolaboratories Products Offered 7.22.5 Alpha Biolaboratories Recent Development 7.23 Test Me DNA 7.23.1 Test Me DNA Corporation Information 7.23.2 Test Me DNA Description and Business Overview 7.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.23.4 Test Me DNA Products Offered 7.23.5 Test Me DNA Recent Development 7.24 23 Mofang 7.24.1 23 Mofang Corporation Information 7.24.2 23 Mofang Description and Business Overview 7.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.24.4 23 Mofang Products Offered 7.24.5 23 Mofang Recent Development 7.25 Genetic Health 7.25.1 Genetic Health Corporation Information 7.25.2 Genetic Health Description and Business Overview 7.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.25.4 Genetic Health Products Offered 7.25.5 Genetic Health Recent Development 7.26 DNA Services of America 7.26.1 DNA Services of America Corporation Information 7.26.2 DNA Services of America Description and Business Overview 7.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.26.4 DNA Services of America Products Offered 7.26.5 DNA Services of America Recent Development 7.27 Shuwen Health Sciences 7.27.1 Shuwen Health Sciences Corporation Information 7.27.2 Shuwen Health Sciences Description and Business Overview 7.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.27.4 Shuwen Health Sciences Products Offered 7.27.5 Shuwen Health Sciences Recent Development 7.28 Mapmygenome 7.28.1 Mapmygenome Corporation Information 7.28.2 Mapmygenome Description and Business Overview 7.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.28.4 Mapmygenome Products Offered 7.28.5 Mapmygenome Recent Development 7.29 Full Genomes 7.29.1 Full Genomes Corporation Information 7.29.2 Full Genomes Description and Business Overview 7.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Sales, Revenue and Gross Margin (2017-2022) 7.29.4 Full Genomes Products Offered 7.29.5 Full Genomes Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Direct-to-consumer Disease Risk and Health Genetic Test Industry Chain Analysis 8.2 Direct-to-consumer Disease Risk and Health Genetic Test Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Direct-to-consumer Disease Risk and Health Genetic Test Distributors 8.3 Direct-to-consumer Disease Risk and Health Genetic Test Production Mode & Process 8.4 Direct-to-consumer Disease Risk and Health Genetic Test Sales and Marketing 8.4.1 Direct-to-consumer Disease Risk and Health Genetic Test Sales Channels 8.4.2 Direct-to-consumer Disease Risk and Health Genetic Test Distributors 8.5 Direct-to-consumer Disease Risk and Health Genetic Test Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Direct-to-consumer Disease Risk and Health Genetic Test CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Direct-to-consumer Disease Risk and Health Genetic Test Market Trends Table 3. Direct-to-consumer Disease Risk and Health Genetic Test Market Drivers Table 4. Direct-to-consumer Disease Risk and Health Genetic Test Market Challenges Table 5. Direct-to-consumer Disease Risk and Health Genetic Test Market Restraints Table 6. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Direct-to-consumer Disease Risk and Health Genetic Test Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Manufacturer, 2017-2022 Table 13. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Share by Manufacturer, 2017-2022 Table 15. Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Direct-to-consumer Disease Risk and Health Genetic Test Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Direct-to-consumer Disease Risk and Health Genetic Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Genetic Test as of 2021) Table 18. Top Players of Direct-to-consumer Disease Risk and Health Genetic Test in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Direct-to-consumer Disease Risk and Health Genetic Test Product Type Table 20. Date of International Manufacturers Enter into Direct-to-consumer Disease Risk and Health Genetic Test Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Direct-to-consumer Disease Risk and Health Genetic Test Players in United States Market, Ranking by Revenue (2021) Table 23. United States Direct-to-consumer Disease Risk and Health Genetic Test Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Direct-to-consumer Disease Risk and Health Genetic Test Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Country (2017-2028) & (US$ Million) Table 42. 23andMe Corporation Information Table 43. 23andMe Description and Business Overview Table 44. 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. 23andMe Direct-to-consumer Disease Risk and Health Genetic Test Product Table 46. 23andMe Recent Development Table 47. MyHeritage Corporation Information Table 48. MyHeritage Description and Business Overview Table 49. MyHeritage Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. MyHeritage Product Table 51. MyHeritage Recent Development Table 52. LabCorp Corporation Information Table 53. LabCorp Description and Business Overview Table 54. LabCorp Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. LabCorp Product Table 56. LabCorp Recent Development Table 57. Myriad Genetics Corporation Information Table 58. Myriad Genetics Description and Business Overview Table 59. Myriad Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Myriad Genetics Product Table 61. Myriad Genetics Recent Development Table 62. Ancestry.com Corporation Information Table 63. Ancestry.com Description and Business Overview Table 64. Ancestry.com Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. Ancestry.com Product Table 66. Ancestry.com Recent Development Table 67. Quest Diagnostics Corporation Information Table 68. Quest Diagnostics Description and Business Overview Table 69. Quest Diagnostics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Quest Diagnostics Product Table 71. Quest Diagnostics Recent Development Table 72. Gene By Gene Corporation Information Table 73. Gene By Gene Description and Business Overview Table 74. Gene By Gene Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Gene By Gene Product Table 76. Gene By Gene Recent Development Table 77. DNA Diagnostics Center Corporation Information Table 78. DNA Diagnostics Center Description and Business Overview Table 79. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. DNA Diagnostics Center Product Table 81. DNA Diagnostics Center Recent Development Table 82. Invitae Corporation Information Table 83. Invitae Description and Business Overview Table 84. Invitae Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Invitae Product Table 86. Invitae Recent Development Table 87. IntelliGenetics Corporation Information Table 88. IntelliGenetics Description and Business Overview Table 89. IntelliGenetics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. IntelliGenetics Product Table 91. IntelliGenetics Recent Development Table 92. Ambry Genetics Corporation Information Table 93. Ambry Genetics Description and Business Overview Table 94. Ambry Genetics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 95. Ambry Genetics Product Table 96. Ambry Genetics Recent Development Table 97. Living DNA Corporation Information Table 98. Living DNA Description and Business Overview Table 99. Living DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 100. Living DNA Product Table 101. Living DNA Recent Development Table 102. EasyDNA Corporation Information Table 103. EasyDNA Description and Business Overview Table 104. EasyDNA Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 105. EasyDNA Product Table 106. EasyDNA Recent Development Table 107. Pathway Genomics Corporation Information Table 108. Pathway Genomics Description and Business Overview Table 109. Pathway Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 110. Pathway Genomics Product Table 111. Pathway Genomics Recent Development Table 112. Centrillion Technology Corporation Information Table 113. Centrillion Technology Description and Business Overview Table 114. Centrillion Technology Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 115. Centrillion Technology Product Table 116. Centrillion Technology Recent Development Table 117. Xcode Corporation Information Table 118. Xcode Description and Business Overview Table 119. Xcode Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 120. Xcode Product Table 121. Xcode Recent Development Table 122. Color Genomics Corporation Information Table 123. Color Genomics Description and Business Overview Table 124. Color Genomics Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 125. Color Genomics Product Table 126. Color Genomics Recent Development Table 127. Anglia DNA Services Corporation Information Table 128. Anglia DNA Services Description and Business Overview Table 129. Anglia DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 130. Anglia DNA Services Product Table 131. Anglia DNA Services Recent Development Table 132. African Ancestry Corporation Information Table 133. African Ancestry Description and Business Overview Table 134. African Ancestry Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 135. African Ancestry Product Table 136. African Ancestry Recent Development Table 137. Canadian DNA Services Corporation Information Table 138. Canadian DNA Services Description and Business Overview Table 139. Canadian DNA Services Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 140. Canadian DNA Services Product Table 141. Canadian DNA Services Recent Development Table 142. DNA Family Check Corporation Information Table 143. DNA Family Check Description and Business Overview Table 144. DNA Family Check Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 145. DNA Family Check Product Table 146. DNA Family Check Recent Development Table 147. Alpha Biolaboratories Corporation Information Table 148. Alpha Biolaboratories Description and Business Overview Table 149. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 150. Alpha Biolaboratories Product Table 151. Alpha Biolaboratories Recent Development Table 152. Test Me DNA Corporation Information Table 153. Test Me DNA Description and Business Overview Table 154. Test Me DNA Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 155. Test Me DNA Product Table 156. Test Me DNA Recent Development Table 157. 23 Mofang Corporation Information Table 158. 23 Mofang Description and Business Overview Table 159. 23 Mofang Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 160. 23 Mofang Product Table 161. 23 Mofang Recent Development Table 162. Genetic Health Corporation Information Table 163. Genetic Health Description and Business Overview Table 164. Genetic Health Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 165. Genetic Health Product Table 166. Genetic Health Recent Development Table 167. DNA Services of America Corporation Information Table 168. DNA Services of America Description and Business Overview Table 169. DNA Services of America Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 170. DNA Services of America Product Table 171. DNA Services of America Recent Development Table 172. Shuwen Health Sciences Corporation Information Table 173. Shuwen Health Sciences Description and Business Overview Table 174. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 175. Shuwen Health Sciences Product Table 176. Shuwen Health Sciences Recent Development Table 177. Mapmygenome Corporation Information Table 178. Mapmygenome Description and Business Overview Table 179. Mapmygenome Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 180. Mapmygenome Product Table 181. Mapmygenome Recent Development Table 182. Full Genomes Corporation Information Table 183. Full Genomes Description and Business Overview Table 184. Full Genomes Direct-to-consumer Disease Risk and Health Genetic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 185. Full Genomes Product Table 186. Full Genomes Recent Development Table 187. Key Raw Materials Lists Table 188. Raw Materials Key Suppliers Lists Table 189. Direct-to-consumer Disease Risk and Health Genetic Test Customers List Table 190. Direct-to-consumer Disease Risk and Health Genetic Test Distributors List Table 191. Research Programs/Design for This Report Table 192. Key Data Information from Secondary Sources Table 193. Key Data Information from Primary Sources List of Figures Figure 1. Direct-to-consumer Disease Risk and Health Genetic Test Product Picture Figure 2. Global Direct-to-consumer Disease Risk and Health Genetic Test Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Size 2017-2028 (US$ Million) Figure 4. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales 2017-2028 (K Units) Figure 5. United States Direct-to-consumer Disease Risk and Health Genetic Test Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Direct-to-consumer Disease Risk and Health Genetic Test Market Size 2017-2028 (US$ Million) Figure 7. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales 2017-2028 (K Units) Figure 8. United States Direct-to-consumer Disease Risk and Health Genetic Test Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Direct-to-consumer Disease Risk and Health Genetic Test Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Direct-to-consumer Disease Risk and Health Genetic Test Report Years Considered Figure 11. Product Picture of Celiac Disease Figure 12. Product Picture of Parkinson Disease Figure 13. Product Picture of Alzheimer Disease Figure 14. Product Picture of Other Figure 15. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Type in 2022 & 2028 Figure 16. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Value by Type (2017-2028) Figure 18. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028) & (K Units) Figure 19. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Type (2017-2028) & (USD/Unit) Figure 21. United States Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Type in 2022 & 2028 Figure 22. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Value by Type (2017-2028) Figure 24. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales by Type (2017-2028) & (K Units) Figure 25. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Direct-to-consumer Disease Risk and Health Genetic Test Price by Type (2017-2028) & (USD/Unit) Figure 27. Product Picture of Online Figure 28. Product Picture of Offline Figure 29. Global Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Application in 2022 & 2028 Figure 30. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Value by Application (2017-2028) Figure 32. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028) & (K Units) Figure 33. Global Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Direct-to-consumer Disease Risk and Health Genetic Test Price by Application (2017-2028) & (USD/Unit) Figure 35. United States Direct-to-consumer Disease Risk and Health Genetic Test Market Share by Application in 2022 & 2028 Figure 36. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Value by Application (2017-2028) Figure 38. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales by Application (2017-2028) & (K Units) Figure 39. United States Direct-to-consumer Disease Risk and Health Genetic Test Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Direct-to-consumer Disease Risk and Health Genetic Test Price by Application (2017-2028) & (USD/Unit) Figure 41. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Growth Rate 2017-2028 (K Units) Figure 42. North America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Growth Rate 2017-2028 (K Units) Figure 46. Europe Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Growth Rate 2017-2028 (K Units) Figure 53. Asia-Pacific Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Growth Rate 2017-2028 (K Units) Figure 65. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales in Volume Growth Rate 2017-2028 (K Units) Figure 70. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Direct-to-consumer Disease Risk and Health Genetic Test Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Direct-to-consumer Disease Risk and Health Genetic Test Value Chain Figure 75. Direct-to-consumer Disease Risk and Health Genetic Test Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

23andMe MyHeritage LabCorp Myriad Genetics Ancestry.com Quest Diagnostics Gene By Gene DNA Diagnostics Center Invitae IntelliGenetics Ambry Genetics Living DNA EasyDNA Pathway Genomics Centrillion Technology Xcode Color Genomics Anglia DNA Services African Ancestry Canadian DNA Services DNA Family Check Alpha Biolaboratories Test Me DNA 23 Mofang Genetic Health DNA Services of America Shuwen Health Sciences Mapmygenome Full Genomes